...
首页> 外文期刊>Journal of Medicinal Chemistry >Antagonists of the Calcium Receptor I. Amino Alcohol-Based Parathyroid Hormone Secretagogues
【24h】

Antagonists of the Calcium Receptor I. Amino Alcohol-Based Parathyroid Hormone Secretagogues

机译:钙受体拮抗剂I.氨基酒精基甲状旁腺激素促分泌剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Functional screening of the former SmithKline Beecham compound collection against the human calcium receptor (CaR) resulted in the identification of the amino alcohol-based hit 2 (IC50 = 11 mu M)Structure-activity Studies of 2 focused on the optimization of the right- and left-hand side aromatic moieties as well as the amino alcohol linker region. Critical to the optimization of this antagonist template was the discovery that the chirality of the C-2 secondary alcohol played a key role in enhancing both CaR potency as well as selectivity over the beta-adrenergic receptor subtypes. These SAR studies ultimately led to the identification of 38 (NPS 2143; SB-262470A), a potent and orally active CaR antagonist. Pharmacokinetic characterization of 38 in the rat revealed that this molecule had a large volume of distribution (11 L/kg), which resulted in a prolonged systemic exposure, protracted increases in the plasma levels of PTH, and an overall lack of net bone formation effect in a rodent model of osteoporosis.
机译:对以前的SmithKline Beecham化合物集合进行针对人类钙受体(CaR)的功能筛选后,鉴定出了基于氨基醇的打击蛋白2(IC50 = 11μM)。结构活性研究2致力于优化右链和左侧的芳族部分以及氨基醇连接子区域。优化此拮抗剂模板的关键在于发现C-2仲醇的手性在增强CaR效能以及相对于β-肾上腺素受体亚型的选择性中起关键作用。这些SAR研究最终导致鉴定出38(NPS 2143; SB-262470A),一种有效的口服活性CaR拮抗剂。在大鼠中38的药代动力学特征表明,该分子具有较大的分布体积(11 L / kg),导致全身暴露时间延长,PTH血浆水平持续升高以及总体上缺乏净骨形成作用在骨质疏松症的啮齿动物模型中。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号